NCT00101621 2006-02-09Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer PainMetaPhore PharmaceuticalsPhase 2 Terminated24 enrolled
NCT00033956 2005-06-24Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2MetaPhore PharmaceuticalsPhase 1/2 Suspended48 enrolled